Wedmont Private Capital Perkinelmer Inc Transaction History

Wedmont Private Capital

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$120.16 - $144.38 $151,401 - $181,918	-1,260 Reduced 39.05%	1,967 $262,000
Q4 2022 Jan 09, 2023	BUY	$119.0 - $147.98 $109,480 - $136,141	920 Added 39.88%	3,227 $0
Q3 2022 Oct 03, 2022	SELL	$118.07 - $160.96 $20,544 - $28,007	-174 Reduced 7.01%	2,307 $278,000
Q2 2022 Jul 11, 2022	BUY	$134.91 - $172.49 $108,737 - $139,026	806 Added 48.12%	2,481 $353,000
Q1 2022 Apr 05, 2022	SELL	$162.31 - $192.2 $32,948 - $39,016	-203 Reduced 10.81%	1,675 $285,000
Q4 2021 Jan 14, 2022	BUY	$166.66 - $201.06 $312,987 - $377,590	1,878 New	1,878 $337,000

574

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

Stay updated on Wedmont Private Capital with notifications on news.